Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia

Abstract. To provide a basis for treating postherpetic neuralgia (PHN), we compared the efficacy of lidocaine and ropivacaine stellate ganglion block (SGB) in PHN treatment in the upper limbs. Data from 252 patients with upper-limb PHN were retrospectively analyzed. The lidocaine group (n = 118) was...

Full description

Bibliographic Details
Main Authors: Zhouhong Fan, Xin Zheng, Dongbai Li, Haopeng Chen, Lingchao Li
Format: Article
Language:English
Published: Wolters Kluwer 2022-06-01
Series:Medicine
Online Access:http://journals.lww.com/10.1097/MD.0000000000029394
_version_ 1818470540477726720
author Zhouhong Fan
Xin Zheng
Dongbai Li
Haopeng Chen
Lingchao Li
author_facet Zhouhong Fan
Xin Zheng
Dongbai Li
Haopeng Chen
Lingchao Li
author_sort Zhouhong Fan
collection DOAJ
description Abstract. To provide a basis for treating postherpetic neuralgia (PHN), we compared the efficacy of lidocaine and ropivacaine stellate ganglion block (SGB) in PHN treatment in the upper limbs. Data from 252 patients with upper-limb PHN were retrospectively analyzed. The lidocaine group (n = 118) was treated with oral pregabalin capsules 75 mg twice a day, tramadol hydrochloride sustained release tablets 100 mg twice a day, and amitriptyline 25 mg once at night combined with ultrasound-guided lidocaine SGB; the ropivacaine group (n = 134) was orally administered the same medicines combined with ultrasound-guided ropivacaine SGB. The visual analog scale (VAS), self-rating anxiety scale (SAS), and adverse reactions were compared between the groups before treatment and at 1 week, 1 month, and 3 months after treatment. There were no significant differences between the lidocaine and ropivacaine groups in terms of sex, age, height, weight, and pain duration (P > .05). There was no significant difference between the groups in VAS and SAS scores before treatment (P > .05). At 1 week, 1 month, and 3 months after ultrasound-guided SGB treatment, the VAS and SAS scores were significantly lower in the ropivacaine group than in the lidocaine group (P < .05). There were no significant differences between the groups in terms of adverse reactions (P > .05). For ultrasound-guided SGB treatment of upper limb PHN, ropivacaine is superior to lidocaine. Ultrasound-guided ropivacaine SGB is safe and effective for the treatment of upper limb PHN.
first_indexed 2024-04-13T21:38:21Z
format Article
id doaj.art-cb9ac03139544777a8f7d8945f23adcf
institution Directory Open Access Journal
issn 0025-7974
1536-5964
language English
last_indexed 2024-04-13T21:38:21Z
publishDate 2022-06-01
publisher Wolters Kluwer
record_format Article
series Medicine
spelling doaj.art-cb9ac03139544777a8f7d8945f23adcf2022-12-22T02:28:51ZengWolters KluwerMedicine0025-79741536-59642022-06-0110123e2939410.1097/MD.0000000000029394202206100-00007Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgiaZhouhong FanXin ZhengDongbai LiHaopeng ChenLingchao LiAbstract. To provide a basis for treating postherpetic neuralgia (PHN), we compared the efficacy of lidocaine and ropivacaine stellate ganglion block (SGB) in PHN treatment in the upper limbs. Data from 252 patients with upper-limb PHN were retrospectively analyzed. The lidocaine group (n = 118) was treated with oral pregabalin capsules 75 mg twice a day, tramadol hydrochloride sustained release tablets 100 mg twice a day, and amitriptyline 25 mg once at night combined with ultrasound-guided lidocaine SGB; the ropivacaine group (n = 134) was orally administered the same medicines combined with ultrasound-guided ropivacaine SGB. The visual analog scale (VAS), self-rating anxiety scale (SAS), and adverse reactions were compared between the groups before treatment and at 1 week, 1 month, and 3 months after treatment. There were no significant differences between the lidocaine and ropivacaine groups in terms of sex, age, height, weight, and pain duration (P > .05). There was no significant difference between the groups in VAS and SAS scores before treatment (P > .05). At 1 week, 1 month, and 3 months after ultrasound-guided SGB treatment, the VAS and SAS scores were significantly lower in the ropivacaine group than in the lidocaine group (P < .05). There were no significant differences between the groups in terms of adverse reactions (P > .05). For ultrasound-guided SGB treatment of upper limb PHN, ropivacaine is superior to lidocaine. Ultrasound-guided ropivacaine SGB is safe and effective for the treatment of upper limb PHN.http://journals.lww.com/10.1097/MD.0000000000029394
spellingShingle Zhouhong Fan
Xin Zheng
Dongbai Li
Haopeng Chen
Lingchao Li
Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
Medicine
title Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
title_full Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
title_fullStr Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
title_full_unstemmed Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
title_short Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
title_sort comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia
url http://journals.lww.com/10.1097/MD.0000000000029394
work_keys_str_mv AT zhouhongfan comparisonoflidocaineandropivacainestellateganglionblockadeintreatingupperlimbpostherpeticneuralgia
AT xinzheng comparisonoflidocaineandropivacainestellateganglionblockadeintreatingupperlimbpostherpeticneuralgia
AT dongbaili comparisonoflidocaineandropivacainestellateganglionblockadeintreatingupperlimbpostherpeticneuralgia
AT haopengchen comparisonoflidocaineandropivacainestellateganglionblockadeintreatingupperlimbpostherpeticneuralgia
AT lingchaoli comparisonoflidocaineandropivacainestellateganglionblockadeintreatingupperlimbpostherpeticneuralgia